BOGLE INVESTMENT MANAGEMENT L P /DE/ - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 93 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$499,000
+18.5%
41,007
+144.3%
0.03%
+17.9%
Q4 2014$421,000
-76.9%
16,785
-71.3%
0.03%
-76.3%
Q3 2014$1,819,000
-57.4%
58,495
-65.2%
0.12%
-67.2%
Q4 2013$4,270,000
+24.4%
168,2680.0%0.36%
+3.4%
Q3 2013$3,432,000
+477.8%
168,268
+493.5%
0.35%
+376.7%
Q2 2013$594,00028,3530.07%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders